SHERRIE MONTELLANO: Open Payments
NPI 1144662354 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 42 payments from 13 companies in 2025. Trend: 2023 $26 · 2024 $158 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $330 |
| PFIZER INC. | 10 | $211 |
| UCB, Inc. | 2 | $84 |
| Lundbeck LLC | 4 | $60 |
| TG Therapeutics, Inc. | 2 | $54 |
| Merz Pharmaceuticals, LLC | 2 | $51 |
| Lilly USA, LLC | 3 | $50 |
| Biogen, Inc. | 2 | $38 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: QULIPTA, NURTEC ODT, VYEPTI, BRIUMVI, Xeomin, AMYVID, Rystiggo, UBRELVY.
Industry payments across AR — which companies pay providers there.
